Waldenström and IgM disorders

Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

Gustine JN, Szalat RE, Staron A, Joshi T, Mendelson L, Sloan JM, Sanchorawala V

Haematologica108(6):1680-1684DOI: Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomesPubMed: Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Bazarbachi AH, Avet-Loiseau H, Szalat R, …, Samur MK

Blood138(20):1980-1985DOI: IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WMPubMed: IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease

Cohen C, Royer B, Javaugue V, Szalat R, …, Bridoux F

Kidney International88(5):1135-1143DOI: Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition diseasePubMed: Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease

Clinico‐biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases

Harel S, Mohr M, Jahn I, …, Szalat R, …, Fermand J

British Journal of Haematology168(5):671-678DOI: Clinico‐biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 casesPubMed: Clinico‐biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases

Genomic and Transcriptomic Characterization of IgM Multiple Myeloma Identifies a Pre-Germinal Center Plasma Cell Disorder with Immature B-Cell Transcription-Factor Signature

Bazarbachi AH, Avet-Loiseau H, Hunter ZR, Szalat R, …, Munshi NC

Blood136(Supplement 1):7-8DOI: Genomic and Transcriptomic Characterization of IgM Multiple Myeloma Identifies a Pre-Germinal Center Plasma Cell Disorder with Immature B-Cell Transcription-Factor Signature

IgM Hevylite Assay as a Biomarker of Clinical Outcome in Patients with Anti-MAG Neuropathy: P-457

ARNULF B, BENGOUFA D, LAZARETH A, SZALAT R, MALPHETTES M, et al.

Clinical Lymphoma, Myeloma & Leukemia13:s254-s255